ArticleCureus2025
Mediastinal Extramedullary Plasmacytoma in the Absence of Classical Myeloma Markers: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple myeloma (MM) typically presents with bone pain, pathological fractures, anemia, renal impairment, or detectable monoclonal gammopathy. In rare instances, MM may manifest with extramedullary plasmacytomas, and mediastinal involvement can challenge diagnostic expectations. We report the case of a 69-year-old man presenting with severe shoulder pain and progressive dyspnea who was found to have a large anterior mediastinal mass, bilateral pleural effusion, and multiple bone lesions. Routine laboratory evaluation revealed no anemia, renal dysfunction, or detectable monoclonal protein on serum protein electrophoresis. However, serum-free light chain assay revealed markedly elevated lambda chains. Biopsy confirmed plasmacytoma. The final diagnosis was light chain MM with mediastinal extramedullary plasmacytoma. This case underscores the importance of considering plasmacytoma in the differential diagnosis of mediastinal masses, even when classical laboratory markers of myeloma are absent, and highlights the pivotal role of histopathology and advanced laboratory testing in establishing a timely diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.